832
Participants
Start Date
June 30, 2008
Primary Completion Date
July 31, 2009
Study Completion Date
July 31, 2009
Irbesartan - Hydrochlorothiazide
150/12.5 mg (1 tablet once daily) or 300/25 mg (1 tablet once daily) depending on the control of the blood pressure. Duration of treatment : 10 weeks
Irbesartan - Hydrochlorothiazide
150/12.5 mg (1 tablet once daily) or 300/25 mg (1 tablet once daily) depending on the control of the blood pressure. Treatment duration : 10 weeks
Sanofi-Aventis Administrative Office, Algiers
Sanofi-Aventis Administrative Office, Buenos Aires
Sanofi-Aventis Administrative Office, São Paulo
Sanofi-Aventis Administrative Office, Bogotá
Sanofi-Aventis Administrative Office, Quito
Sanofi-Aventis Administrative Office, Cairo
Sanofi-Aventis Administrative Office, Guatemala City
Sanofi-Aventis Administrative Office, Beirut
Sanofi-Aventis Administrative Office, Col. Coyoacan
Sanofi-Aventis Administrative Office, Casablanca
Sanofi-Aventis Administrative Office, Panama City
Sanofi-Aventis Administrative Office, Lima
Sanofi-Aventis Administrative Office, Jeddah
Sanofi-Aventis Administrative Office, Mégrine
Sanofi-Aventis Administrative Office, Dubai
Sanofi-Aventis Administrative Office, Caracas
Lead Sponsor
Sanofi
INDUSTRY